Hepatitis B and pregnancy

##plugins.themes.academic_pro.article.sidebar##

Published May 20, 2010
Download
pdf
Vol. 88 No. 6 (2010): Issue Jun 2010

##plugins.themes.academic_pro.article.main##

Dalenda Arfaoui
Meriem Fkih
Alaa Eddine Hafsa
Naoufel Kaabia
Msadek Azzouz

Abstract

Background : Chronic Hepatitis B infection can lead to liver cirrhosis and hepatocellular carcinoma. In women, these viral infections can be responsible for transmission to the husband and to the child during delivery.
Aim : The purpose of this review is to analyze from the literature the mechanism of mother-to-child transmission and the consequences.
Methods: We conducted a review of the literature through the interrogation of the MEDLINE database using a query documentary by combining the Boolean (AND) keywords (MeSH) as follows: «hepatitis B»; «Vertical transmission»; «Pregnancy»; «Delivery».
Results : Hepatitis B virus transmission by sexual contact in low prevalence areas and infection occurs during either the perinatal period or early in childhood in moderate or high prevalence areas. In Tunisia, the prevalence of Antigen HBS (HBs Ag) with pregnant women is 3 to 4%. The risk of maternal-infant contamination is high, from 20 to 90 per cent according to the viral load in the mother. Mother-to-child transmission can be avoided by serovaccination of the newborn.The women with very high viral loads may receive lamivudine treatment at the end of pregnancy to diminish viral load and thus the risk of chronic carriage in the child; however the role of this drug in this situation is not yet clearly defined

Keywords:

hepatitis B, Vertical transmission, Pregnancy, Delivery

##plugins.themes.academic_pro.article.details##

References

  1. Organisation Mondiale de la Santé. Hépatite B. Fact sheet N°204. Revised August 2008
  2. Hurie MB, Mast EE, Davis JP. Horizontal transmission of hepatitis B virus infection to United States-born children of Hmong refugees. Pediatrics 1992; 89: 269-73.3.
  3. Lee WM. Hepatitis B virus infection. N Engl J Med 1997; 337: 1733- 452.
  4. Ngui SL, Andrews NJ, Underhill GS, Heptonstall J, Teo CG. Failed postnatal immunprophylaxis for hepatitis B: characteristics of maternal hepatitis B virus as risk factors. Clin Infect Dis 1998 ; 27 : 100-6.
  5. Denis F, Tabaste JL, Ranger-Rogez S. Prévalence de l'Ag HBs chez près de 21500 femmes enceintes. Enquête douze CHU français. Pathol Biol 1994 ; 42 : 533-8.
  6. Denis F, Ranger-Rogez S, Alain S, et al. Screening of pregnant women for hepatitis B markers in a French Provincial University Hospital(Limoges) during 15 years. Eur J Epidemiol 2004; 19: 973-8.
  7. Marinler E, Barrols V, Larouze B. Transmission materno-f?tale du virus Ç de l'hépatite en Côte d'Ivoire. Cahiers Santé, 1998; 8: 401-4.
  8. 8-Kuri U, Turan O, Kuru N, et al . Prevalence of hepatitis B virus infection in pregnant Turkish women and their families. Eur J Clin Microbiol Infect Dis 1996; 15 :248-51
  9. Panagopoulos P, Economou A, Kassi,I A et al . Prevalence of hepatitis B and C in the maternity department in a Greek district hospital . J Matern Fetal Neonatal Med 2004; 16 :106- 10
  10. Elefsiniotis IS, Glynou I, Magaziotou I. HBe Ag negative serological status and low viral replication levels characterize chronic hepatitis B virus-infected women at reproductive age in Greece: A one-year prospective single center study. World J Gastroenterol 2005; 11:4879-82.
  11. Coursaget P, Gharbi Y, Khrouf N ,et al. Familial clustering of hepatitis B virus infections and prevention of perinatal transmission by immunization with a reduced number of doses in an area of intermediate endemicity( Tunisia). Vaccine 1994; 12 : 257- 8
  12. Soltani MS,Bechir A, Slimane MN, Mtiraoui A, Ghannem H. Mother-child transmission of hepatitis B virus in the Tunisian Sahel.Rev Epidemiol Santé Publique 1994; 42 : 529-32
  13. Hannachi N, bahri O,Mhalla S, et al . Hépatite B chez les femmes enceintes tunisiennes : facteurs de risque et intérêt de l'étude de réplication virale en cas d'antigène HBe négatif. PatholBiol 2008 ;4 :2649-53
  14. Ranger-Rogez S, Alain S, Denis F. Virus des hépatites : transmission mère-enfant. Pathol Biol 2002;50:568-75.
  15. Rawal BK, Paridas S, Watkins RP, Ghosh P, Smith H. Symptomatic reactivation of hepatitis B in pregnancy. Lancet 1991; 337: 364.
  16. Soderstrom A, Norkrans G, Lindth. Hepatitis B virus DNA during pregnancy and post partum: aspects on vertical transmission. Scand J Infect Dis 2003; 35: 814- 9.
  17. Xu DZ, Yan YP, Choi BC et al. Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study. J Med Virol 2002; 67: 20-6.
  18. Zhang SL, Han XB and Yue YF. Relationship between HBV viremia level of pregnant women and intrauterine infection: nested PCR for detection of HBV DNA. WJG 1998 4: 61-3
  19. Ghendon Y. Perinatal transmission of hepatitis B virus in highincidence countries. J Virol Methods 1987; 17: 69-79.
  20. Tse K Y, Ho L F, Lao T. The impact of maternal HBs Ag carrier status on pregnancy outcomes: Acase-control study. Journal of Hepatology 2005;43: 771-775.
  21. Lee AK, Ip HM, Wong VC. Mechanisms of maternal-fetal transmission of hepatitis B virus. J Infect Dis 1978; 138: 668- 71.
  22. Schweitzer IL. Vertical transmission of the hepatitis B surface antigen. Am J Med Sci 1975; 270: 287-91.
  23. Towers CV, Asrat, Rumney P. The presence of hepatitis B surface antigen and deoxyribonucleic acid in amniotic fluid and cord blood. Am J. Obstet Gynecol 2001 184 : 1514-18.
  24. Alexander JM, Ramus R, Jackson G, Sercely B, Wendel GD. Risk of hepatitis B transmission after amniocentesis in chronic hepatitis B carriers. Infect Dis Obstet Gynecol 1999; 7: 283-6.
  25. Wang J. Zhu Q. Zhang X. Effect of delivery mode on maternal-infant transmission of hepatitis B virus by immunoprophylaxis. Chin Med J. 2002;115: 1510-12.
  26. Elective caesarean section versus vaginal delivery for preventing mother to child transmission of hepatitis B virus - a systematic review . Yang J, Zeng X, Men Y, Zhao L . J Virol. 2008; 5: 100.
  27. Hill JB, Sheffield JS, Kim MJ, Alexander JM, Sercely B, Wendel GD. Risk of hepatitis B transmission in breast-fed infants of chronic hepatitis B carriers. Obstet Gynecol 2002 99 : 1049-52.
  28. World Health Organization. Hepatitis B and breast feeding. J Int Assoc Physicians AIDS Care 1998; 4:20-1.
  29. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis 1995; 20:992-1000.
  30. McMahon BJ, Alberts SR, Wainwright RB et al. Hepatitis B-related sequelae: prospective study in 1400 hepatitis B surface antigenpositive Alaska native carriers. Arch Intern Med 1990; 150: 1051-4.
  31. Ranger-Rogez S, Denis F. Hepatitis B mother-to-child transmission. Expert Rev Anti-infective Ther 2004;2 : 133-45.
  32. Zuckermann JN. Hepatitis B immune globulin for prevention of hepatitis B infection. J Med Virol 2007; 79: 919-21.
  33. Lee C, Gong Y, Brok J, Boxall EH, Gluud C Effect of hepatitis B immunisation in newborn infants of mothers positive for hepatitis B surface antigen: systematic review and meta-analysis. BMJ. 2006 ; 332: 328-36.
  34. Del Canho R, Grosheide PM , Mazel JA. Ten-year neonatal hepatitis B vaccination program. The Netherlands, 1982-1992 : protective efficacy and long-term immunogenicity. Vaccine 1997 15 : 1624-30.
  35. Vranckx R, Alisjahbana A, Meheus A. Hepatitis B virus vaccination and antenatal transmission of HBV markers to neonates.JViral Hepat 1999 6 : 135-9.
  36. Velu V, Nandakumar S, Shanmugam S, et al . Comparison of three different recombinant hepatitis B vaccines: GeneVac-B, Engerix B and Shanvac B in high risk infants born to HBsAg positive mothers in India .World J Gastroenterol 2007 ; 13 : 3084-9.
  37. Mele A, Tancredi F, Romano L et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184 : 905-8.
  38. Huang K, Lin S. Nationwide vaccination: a success story in Taïwan. Vaccine 2000; 18 (Suppl. 1): S35-8.
  39. Chang MH, Chen CJ, Lai MS, et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997 336: 1855-9. 32.
  40. Lemon SM, Thomas DL. Vaccines to prevent viral hepatitis. N Eng J Med 1997; 336: 196-204.
  41. Roome A, Rak M, Hadler J. Follow-up of infants of hepatitis Binfected women after hepatitis B vaccination, Connecticut, 1994 to 1997. Pediatr Infect Dis J 2000 ; 19 : 573-5. 11.
  42. Soulie JC, Uzan M. L'allaitement accroît-il le risque de transmission de l'état de porteur chronique du virus de l'hépatite B ? Gastroenterol Clin Biol. 1997 ; 21: 197-9.
  43. Huang LM, Chiang BL, Lee CY, et al. Long-term response to hepatitis B vaccination and response to booster in children born to mothers with hepatitis B. Hepatology 1999; 29: 954-9.
  44. Keeffe EB, Dieterich DT, Han SH, et al. A treatement algorithm for the management of chronic hepatitis B virus infection in the United States: an update. Clin Gastroenterol hepatol 2006; 4: 936- 62.
  45. EASL Clinical Practice Guidelines: Management of chronic hepatitis B. J Hepatology 2009; 50: 227-242
  46. Terrault NA, Jacobson IM. Treating chronic hepatitis B infection in patients who are pregnant or are undergoing immunosuppressive chemotherapy. Emin Liver Dis 2007; 27(suppl 1) : 18- 24.
  47. Xu WM, Cui YT, Wang L,Yang H, Liang Z Q,Li XM.Efficacy and safety of lamivudine in late pregnancy for the prevention of motherchild transmission of hepatitis B; a multicentre, randomised, double blind placebo controled study. Hepatology 2004; 40(suppl 1):272 A
  48. Su GG, Pan KH, Whao NF, Fang SH, Yang DH, Whou Y. Efficacy and safety of lamivudine treatement for chronic hepatitis B in pregnancy. World J Gastroenterol 2004; 10: 910-2
  49. Kazim SN, Wakil SM, Khan LA, Hasnain SE, Sarin SK. Vertical transmission of hepatitis B virus despite maternal lamivudine therapy. Lancet 2002 ; 359 : 1488-9.
  50. Van Zonneved M ,Van Nunen AB,Niesters HG et al. Lamivudine treatement during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J Viral Hepatol 2003 ; 10 : 294-7.
  51. Xu WM, Cui YT, Wang L, et al. Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study. J Viral Hepat. 2009;16 :94-103.
  52. Li XM, Yang YB, Hou HY, Shi ZJ, Shen HM, Teng BP, Li AM, Shi MF, Zou L. Interruption of HBV intrauterine transmission : a clinical study. World J. Gastroenterol. 2003 9 : 1501-3.
  53. Li X, Shi M F, Yang Y B, et al. Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection. World J Gastroenterol 2004;10 :3215-3217.
  54. Xu Q, Xiao L, Lu X B, Zhang Y X, Cai X. A randomized controlled clinical trial: Interruption of intrauterine transmission of hepatitis B virus infection with HBIG. World J Gastroenterol 2006 ; 12 : 3434- 7.
  55. Leruez M, Dulioust E, Galimand J, Guibert J , Jouannet P, Rouzioux C. Virus et sperme : implications pour l'assistance médicale à la procréation Immuno-analyse & Biologie spécialisée 2006 ; 21:181-8.
  56. Huang JM, Huang TH, Qiu HY, Fang XW, Zhuang TG, Liu HX, et al. Effects of hepatitis B virus infection on human sperm chromosomes. World J Gastroenterol 2003;9:736-40.
  57. Honeck P, Weigel M, Kwon S T, Alken P,Bross S. Assisted procreation in cases of hepatitis B, hepatitis C or human immunodeficiency virus infection of the male partner. Human Reproduction 2006; 21 : 1117-21.